Peginterferon alfa‐2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy

BACKGROUND: The management of patients with chronic hepatitis C who have relapsed or failed to respond to interferon based therapies is an important issue facing hepatologists. AIMS: We evaluated the efficacy and safety of peginterferon alfa‐2a (40KD) plus ribavirin in this population by conducting...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sherman, M, Yoshida, E M, Deschenes, M, Krajden, M, Bain, V G, Peltekian, K, Anderson, F, Kaita, K, Simonyi, S, Balshaw, R, Lee, S S
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2006
Assuntos:
Hepatitis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1860092/
https://ncbi.nlm.nih.gov/pubmed/16709661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2005.083113
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados